Evaluation of an HPV vaccine toolkit to improve OB/GYN discussion of HPV vaccination
Background: HPV (Human Papillomavirus) vaccination is a safe, effective method to prevent HPV-associated disease. Racial-ethnic disparities in HPV vaccination exist, which could lead to widening gaps in cervical cancer mortality. Provider discussion of HPV vaccination has been shown to be a primary...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Public Health in Practice |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666535224000107 |
_version_ | 1797316804966612992 |
---|---|
author | Sarah Simko Teodocia Maria Hayes-Bautista Erica Givens |
author_facet | Sarah Simko Teodocia Maria Hayes-Bautista Erica Givens |
author_sort | Sarah Simko |
collection | DOAJ |
description | Background: HPV (Human Papillomavirus) vaccination is a safe, effective method to prevent HPV-associated disease. Racial-ethnic disparities in HPV vaccination exist, which could lead to widening gaps in cervical cancer mortality. Provider discussion of HPV vaccination has been shown to be a primary factor for increasing vaccination rates. The objective of this study is to assess provider discussion of HPV vaccination pre and post implementation of an intervention, named the HPV Vaccine Toolkit, in an Obstetrics and Gynecology (OB/GYN) clinic in Boyle Heights, Los Angeles. Study design and methods: This quality improvement study occurred over four cycles of development. Its design was guided by the Theory of Planned Behavior. The toolkit components included dot phrases (pre-written phrases to speed documentation), educational posters, electronic health record prompts, HPV vaccine referral guides, and educational sessions. Chart audits and pre- and post-providers surveys were performed between 2019 and 2021 to assess for an increase in provider discussion of the HPV vaccine, as well as to evaluate the various components of the toolkit. Results: Provider discussion increased over the four cycles of this intervention, with HPV vaccination discussion documented in 15 % of patients in 2019, 19 % of patients in 2020 and 47 % of patients in 2021. Gaps identified included limited discussion of vaccination at postpartum visits. Provider uncertainty of where to refer patients for the HPV vaccine decreased following the intervention. Conclusion: Discussion of HPV vaccination is an important preventative strategy that can be overlooked in OB/GYN clinics. Implementation of multicomponent strategies can increase provider discussion of HPV vaccination status, although barriers to discussion remain. Improved counseling on HPV vaccination could have significant impacts on reducing HPV-related disease. |
first_indexed | 2024-03-08T03:24:39Z |
format | Article |
id | doaj.art-a66adc369c5f47669183586d69ea1ae8 |
institution | Directory Open Access Journal |
issn | 2666-5352 |
language | English |
last_indexed | 2024-03-08T03:24:39Z |
publishDate | 2024-06-01 |
publisher | Elsevier |
record_format | Article |
series | Public Health in Practice |
spelling | doaj.art-a66adc369c5f47669183586d69ea1ae82024-02-12T04:06:46ZengElsevierPublic Health in Practice2666-53522024-06-017100473Evaluation of an HPV vaccine toolkit to improve OB/GYN discussion of HPV vaccinationSarah Simko0Teodocia Maria Hayes-Bautista1Erica Givens2University of California at Riverside, Riverside, CA, USA; Corresponding author. University of California at Riverside School of Medicine, 19330 Jesse Ln STE 100, Riverside, CA, 92508, USA.Adventist Health White Memorial Medical Center, Los Angeles, CA, USAAdventist Health White Memorial Medical Center, Los Angeles, CA, USABackground: HPV (Human Papillomavirus) vaccination is a safe, effective method to prevent HPV-associated disease. Racial-ethnic disparities in HPV vaccination exist, which could lead to widening gaps in cervical cancer mortality. Provider discussion of HPV vaccination has been shown to be a primary factor for increasing vaccination rates. The objective of this study is to assess provider discussion of HPV vaccination pre and post implementation of an intervention, named the HPV Vaccine Toolkit, in an Obstetrics and Gynecology (OB/GYN) clinic in Boyle Heights, Los Angeles. Study design and methods: This quality improvement study occurred over four cycles of development. Its design was guided by the Theory of Planned Behavior. The toolkit components included dot phrases (pre-written phrases to speed documentation), educational posters, electronic health record prompts, HPV vaccine referral guides, and educational sessions. Chart audits and pre- and post-providers surveys were performed between 2019 and 2021 to assess for an increase in provider discussion of the HPV vaccine, as well as to evaluate the various components of the toolkit. Results: Provider discussion increased over the four cycles of this intervention, with HPV vaccination discussion documented in 15 % of patients in 2019, 19 % of patients in 2020 and 47 % of patients in 2021. Gaps identified included limited discussion of vaccination at postpartum visits. Provider uncertainty of where to refer patients for the HPV vaccine decreased following the intervention. Conclusion: Discussion of HPV vaccination is an important preventative strategy that can be overlooked in OB/GYN clinics. Implementation of multicomponent strategies can increase provider discussion of HPV vaccination status, although barriers to discussion remain. Improved counseling on HPV vaccination could have significant impacts on reducing HPV-related disease.http://www.sciencedirect.com/science/article/pii/S2666535224000107HPV vaccinationProvider discussionCatch-up ImmunizationMulti-componentCancer PreventionBehavior change |
spellingShingle | Sarah Simko Teodocia Maria Hayes-Bautista Erica Givens Evaluation of an HPV vaccine toolkit to improve OB/GYN discussion of HPV vaccination Public Health in Practice HPV vaccination Provider discussion Catch-up Immunization Multi-component Cancer Prevention Behavior change |
title | Evaluation of an HPV vaccine toolkit to improve OB/GYN discussion of HPV vaccination |
title_full | Evaluation of an HPV vaccine toolkit to improve OB/GYN discussion of HPV vaccination |
title_fullStr | Evaluation of an HPV vaccine toolkit to improve OB/GYN discussion of HPV vaccination |
title_full_unstemmed | Evaluation of an HPV vaccine toolkit to improve OB/GYN discussion of HPV vaccination |
title_short | Evaluation of an HPV vaccine toolkit to improve OB/GYN discussion of HPV vaccination |
title_sort | evaluation of an hpv vaccine toolkit to improve ob gyn discussion of hpv vaccination |
topic | HPV vaccination Provider discussion Catch-up Immunization Multi-component Cancer Prevention Behavior change |
url | http://www.sciencedirect.com/science/article/pii/S2666535224000107 |
work_keys_str_mv | AT sarahsimko evaluationofanhpvvaccinetoolkittoimproveobgyndiscussionofhpvvaccination AT teodociamariahayesbautista evaluationofanhpvvaccinetoolkittoimproveobgyndiscussionofhpvvaccination AT ericagivens evaluationofanhpvvaccinetoolkittoimproveobgyndiscussionofhpvvaccination |